Alto Neurosciences is halting work on its schizophrenia prospect after the brain-penetrant drug flunked a phase 2 study. The Bay Area biotech evaluated 10 days of treatment with t ...

A newly identified gene mutation may help explain why schizophrenia patients struggle to update their understanding of ...

Schizophrenia is a severe mental disorder affecting about 1% of the population worldwide, and is notoriously difficult to ...

A new study from the Massachusetts Institute of Technology suggests that a specific gene mutation prevents patients with ...

Axsome Therapeutics Inc. AXSM shares are trading up on Wednesday as the company is expanding its portfolio with the ...

UCSF scientists are in a tight race against time, trying to spot telltale brain signals before a person’s first psychotic ...

Brexpiprazole is linked to reduced symptoms, improved functioning, and greater response compared with placebo in patients ...

For decades, scientists studying brain disorders have focused almost exclusively on proteins and the genes encoding them. Now ...

Caring for a friend or loved one with schizophrenia can often feel all-consuming. You may find yourself sacrificing work, ...

What if one of the most damaging aspects of schizophrenia isn’t a symptom at all, but the crippling impact of social ...